Visual scanning and cognitive performance in prediagnostic and early-stage Huntington's disease
β Scribed by Tanya Blekher; Marjorie R. Weaver; Jeanine Marshall; Siu Hui; Jacqueline Gray Jackson; Julie C. Stout; Xabier Beristain; Joanne Wojcieszek; Robert D. Yee; Tatiana M. Foroud
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 325 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The objective of this study was to evaluate visual scanning strategies in carriers of the Huntington disease (HD) gene expansion and to test whether there is an association between measures of visual scanning and cognitive performance. The study sample included control (NC, n = 23), prediagnostic (PDHD, n = 21), and subjects recently diagnosed with HD (HD, n = 19). All participants completed a uniform clinical evaluation that included examination by neurologist and molecular testing. Eye movements were recorded during completion of the Digit Symbol Subscale (DS) test. Quantitative measures of the subject's visual scanning were evaluated using joint analysis of eye movements and performance on the DS test. All participants employed a simple visual scanning strategy when completing the DS test. There was a significant group effect and a linear trend of decreasing frequency and regularity of visual scanning from NC to PDHD to HD. The performance of all groups improved slightly and in a parallel fashion across the duration of the DS test. There was a strong correlation between visual scanning measures and the DS cognitive scores. While all individuals employed a similar visual scanning strategy, the visual scanning measures grew progressively worse from NC to PDHD to HD. The deficits in visual scanning accounted, at least in part, for the decrease in the DS score. Β© 2008 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract Disturbances of visual cognition, visuomotor performance, and visual memory have been described frequently in Huntington's disease (HD). Early stage visual abnormalities could contribute to these deficits. We evaluated visual processing in 20 control subjects who were nonβgene carriers
## Abstract The importance of designating criteria for diagnosing dementia lies in its implications for clinical treatment, research, caregiving, and decisionβmaking. Dementia diagnosis in Huntington's disease (HD) is often based on criteria developed for Alzheimer's disease requiring memory loss.
## Abstract To evaluate the efficacy of rivastigmine on motor and cognitive impairment in Huntington's disease (HD), we carried out a prospective, openβlabel, randomized, controlled study. Twentyβone HD patients were enrolled: 14 were randomly sorted into medication and 7 to noβtreatment groups. Cl
## Abstract Besides chorea, hypokinesia is an important motor disturbance in Huntington's disease (HD) but its clinical, neuropsychiatric, and cognitive functioning correlates are largely unknown. This crossβsectional study investigates correlates of hypokinesia in HD and its effect on global funct